We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAI
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
PWRD
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.24% |
| 2 | Consumer Discretionary | 5.63% |
| 3 | Healthcare | 3.98% |
| 4 | Industrials | 3.9% |
| 5 | Communication Services | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Merck
MRK
$386B
| $5.52M | 0.07% |
42,950
-11,348
| -21% | -$1.33M |
|
152
Natera
NTRA
$48.5B
| $5.29M | 0.06% |
19,490
+2,564
| +15% | +$547K |
|
153
Oracle
ORCL
$417B
| $5.27M | 0.06% |
35,960
+1,066
| +3% | +$193K |
|
154
AstraZeneca
AZN
$263B
| $5.26M | 0.06% |
27,729
+1,078
| +4% | +$203K |
|
155
iShares Core S&P US Value ETF
IUSV
$28B
| $4.98M | 0.06% |
45,179
-4,353
| -9% | -$471K |
|
156
Martin Marietta Materials
MLM
$37.8B
| $4.89M | 0.06% |
8,486
-5,048
| -37% | -$2.99M |
|
157
Allstate
ALL
$65.2B
| $4.89M | 0.06% |
20,556
-148
| -0.7% | -$32.2K |
|
158
Acuity Brands
AYI
$10.2B
| $4.83M | 0.06% |
12,823
-3,160
| -20% | -$937K |
|
159
Qualcomm
QCOM
$169B
| $4.8M | 0.06% |
25,975
+5,641
| +28% | +$1.05M |
|
160
General Dynamics
GD
$102B
| $4.71M | 0.06% |
13,293
+282
| +2% | +$96.6K |
|
161
iShares Russell 2000 ETF
IWM
$81.7B
| $4.67M | 0.06% |
15,552
+1,483
| +11% | +$417K |
|
162
Vanguard Russell 1000 Growth ETF
VONG
$44.8B
| $4.64M | 0.06% |
36,291
+69
| +0.2% | +$8.56K |
|
|
BNY
163
Bank of New York Mellon
BNY
$111B
| $4.57M | 0.05% |
31,584
+946
| +3% | +$129K |
|
164
First Trust NASDAQ-100 Technology Index Fund
QTEC
$4.68B
| $4.57M | 0.05% |
+13,644
| New | +$3.91M |
|
165
Berkshire Hathaway Class A
BRK.A
$1.08T
| $4.49M | 0.05% |
6
| – | – |
|
166
Paychex
PAYX
$44.5B
| $4.49M | 0.05% |
45,612
+655
| +1% | +$62K |
|
167
iShares Core MSCI International Developed Markets ETF
IDEV
$32.8B
| $4.46M | 0.05% |
50,154
+947
| +2% | +$83.9K |
|
168
iShares US Industrials ETF
IYJ
$1.91B
| $4.4M | 0.05% |
26,381
+6,830
| +35% | +$1.08M |
|
169
Schwab US Broad Market ETF
SCHB
$44.6B
| $4.38M | 0.05% |
+151,368
| New | +$4.24M |
|
170
iShares Core US Aggregate Bond ETF
AGG
$139B
| $4.37M | 0.05% |
44,174
-13,189
| -23% | -$1.3M |
|
171
Ross Stores
ROST
$77.4B
| $4.37M | 0.05% |
20,541
-770
| -4% | -$173K |
|
172
Aon
AON
$75.3B
| $4.3M | 0.05% |
+12,976
| New | +$4.19M |
|
173
Williams Companies
WMB
$86.9B
| $4.29M | 0.05% |
57,692
-937
| -2% | -$69K |
|
174
Applied Materials
AMAT
$381B
| $4.25M | 0.05% |
5,882
+961
| +20% | +$443K |
|
175
EQT Corp
EQT
$33.8B
| $4.16M | 0.05% |
78,311
-35,207
| -31% | -$1.98M |
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.